Related Experiment Video
Updated: Jun 11, 2025

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice
Published on: July 2, 2018
The Role of Inflammation in the Pathogenesis of Cardiogenic Shock Secondary to Acute Myocardial Infarction: A
Irina Kologrivova1, Maria Kercheva1,2, Oleg Panteleev1,2
1Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 111A Kievskaya, Tomsk 634012, Russia.
Insights
Cardiogenic shock (CS) following myocardial infarction (MI) has high mortality. This review explores the systemic inflammatory response in CS pathogenesis, aiming to identify targeted anti-inflammatory therapies for better patient outcomes.
Area of Science:
- Cardiology
- Immunology
- Pathophysiology
Background:
- Cardiogenic shock (CS) is a severe complication of myocardial infarction (MI), associated with high mortality rates.
- Current pharmaco-invasive treatments for MI complicated by CS (MI CS) have limited efficacy, necessitating novel therapeutic strategies.
- The systemic inflammatory response plays a critical role in the progression of MI CS and subsequent multiple organ dysfunction.
Purpose of the Study:
- To review the role of the systemic inflammatory response in the pathogenesis of MI CS.
- To summarize current knowledge on the initiation and progression of inflammation in MI CS.
- To discuss potential anti-inflammatory therapeutic approaches and future research directions.
Main Methods:
- Literature review and synthesis of existing research on inflammation in MI CS.
- Analysis of the progression from MI onset to systemic inflammation and organ dysfunction.
- Discussion of anti-inflammatory strategies and identification of research gaps.
Main Results:
- The systemic inflammatory response is a key driver in MI CS pathogenesis.
- Inflammation progresses from localized myocardial injury to a generalized response, contributing to organ dysfunction.
- Understanding inflammatory pathways is crucial for developing targeted therapies.
Conclusions:
- Targeting the inflammatory component of MI CS pathogenesis offers a promising avenue for improving patient outcomes.
- Identification of specific inflammatory phenotypes and endotypes in MI CS is essential for personalized treatment strategies.
- Further research into anti-inflammatory therapies is warranted to reduce the high mortality associated with MI CS.
Abstract:
Cardiogenic shock (CS) is one of the most serious complications of myocardial infarction (MI) with a high mortality rate. The timely and effective prevention and early suppression of this adverse event may influence the prognosis and outcome in patients with MI complicated by CS (MI CS). Despite the use of existing pharmaco-invasive options for maintaining an optimal pumping function of the heart in patients with MI CS, its mortality remains high, prompting the search for new approaches to pathogenetic therapy. This review considers the role of the systemic inflammatory response in the pathogenesis of MI CS. The primary processes involved in its initiation are described, including the progression from the onset of MI to the generalization of the inflammatory response and the development of multiple organ dysfunction. The approaches to anti-inflammatory therapy in patients with CS are discussed, and further promising research directions are outlined. In this review, we updated and summarized information on the inflammatory component of MI CS pathogenesis with a particular focus on its foundational aspects. This will facilitate the identification of specific inflammatory phenotypes and endotypes in MI CS and the development of targeted therapeutic strategies for this MI complication.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis III: Medical Management
Myocarditis II: Clinical features and Diagnostic Tests
Acute Coronary Syndrome II: Pathophysiology and clinical manifestations
Rheumatic Heart Disease I: Introduction
Inflammation

